Advertisements

Paracetamol Pensa

Quick links to important sections

Paracetamol Pensa

Advertisements

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Paracetamol Pensa

Property Description
Active Ingredient Paracetamol (Acetaminophen, APAP)
Pharmacological Class Analgesic and Antipyretic
Form Tablet / Film-coated tablet
Common Use Symptomatic relief of pain and fever
Origin Synthetic, anilide derivative

Paracetamol Pensa: Definition and Classification

Paracetamol Pensa is a synthetic, single-ingredient pharmaceutical distributed by Pensa Pharma, defined by its active component, Paracetamol. It is officially classified within the therapeutic group of miscellaneous analgesics, which are chemically known as anilide derivatives. The product's identity centers on the single active substance, which is internationally recognized by the synonym Acetaminophen (APAP). This compound is clinically recognized for its established efficacy in fever and pain management.

This dual classification establishes its fundamental role in providing general symptomatic relief. Unlike Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), paracetamol lacks clinically significant anti-inflammatory properties at standard therapeutic concentrations.


Composition and Available Dosage Form

The preparation consists solely of the active ingredient Paracetamol, formulated alongside necessary excipients into a solid oral dosage form, typically a tablet or film-coated tablet, designed for oral administration. The physical form, such as the film-coated tablet, is intended to ensure stability and facilitate easier swallowing. Being a single-ingredient product of synthetic origin, Paracetamol Pensa offers a standardized and consistent delivery vehicle.

The primary goal of the product is to provide effective relief for discomforts such as headaches or general body aches accompanied by fever. The substance is indicated for the symptomatic treatment of pain and fever, confirming that the medication is designed to address general discomfort and elevated body temperature. Its therapeutic purpose is focused on enhancing comfort and managing febrile episodes rather than addressing the underlying causes of the symptoms.

Advertisements

What side effects are possible with Paracetamol Pensa?

Possible Side Effects and Safety Information

The official safety profile for Paracetamol Pensa is defined by the classification of most adverse reactions as rare when the medication is used within therapeutic recommendations. Adverse reactions are grouped by the physiological systems they affect, with regulatory labeling citing effects on Hepatobiliary disorders, the Blood and lymphatic system, Immune system, and Skin and subcutaneous tissue disorders.

Documented Adverse Reactions and Frequencies

Adverse reactions that are classified as Rare (affecting 1 to 10 users in 10,000) include various blood disorders such as thrombocytopenia and agranulocytosis, and various forms of hypersensitivity reactions. Reactions classified as Very Rare (affecting less than 1 user in 10,000) include severe cutaneous adverse reactions (SCARs) like Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).

Serious Safety Considerations and Constraints

The primary serious safety risk is severe hepatotoxicity (liver damage), which is primarily associated with acute overdose or long-term exposure exceeding the recommended limits. Severe hypersensitivity reactions, including anaphylactic shock, are also officially documented but rare risks. The regulatory label places an absolute constraint against the concurrent use of Paracetamol Pensa with any other paracetamol-containing product to prevent accidental over-exposure. Safety considerations are explicitly noted for individuals with pre-existing severe hepatic impairment, where the medicine is typically contraindicated, and for patients with chronic alcoholism.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The information in this section describes the officially documented manifestations of overdose and the actions mandated by government regulatory authorities.

Official Overdose Manifestations

Overdose of Paracetamol (Acetaminophen) is officially documented to carry a risk of delayed, severe hepatotoxicity (liver damage). Initial symptoms may be non-specific or mild, including nausea, vomiting, anorexia, and malaise. The most serious documented outcome is acute liver failure, which may progress without severe early symptoms.

Specific official risk factors that may increase the severity of toxicity following an overdose include pre-existing hepatic impairment, chronic alcoholism, or malnutrition.

Regulatory-Mandated Emergency Actions

Government regulatory guidance mandates that individuals must seek immediate medical attention or contact a poison control center immediately after a suspected overdose. This requirement is critical because the serious outcome—severe hepatic necrosis—may develop in a latent period, even if the patient feels well.

N-acetylcysteine (NAC) is the specific antidote described in regulatory labeling. The efficacy of the antidote is stated to be highest when administered promptly. Management protocols described in official prescribing information require immediate hospital monitoring, including measurement of plasma paracetamol concentration and observation of liver function tests.

Advertisements

Therapeutic Uses of Paracetamol Pensa

What Paracetamol Pensa Treats: Main Uses and Benefits

The primary therapeutic role of this medication is to provide supportive symptomatic assistance in acute and episodic situations, focusing on conditions where heightened discomfort or temperature may be part of symptomatic management. The medication is commonly used to help with symptoms that create noticeable physiological strain and symptoms that interfere with daily comfort.

Symptomatic Relief and Indications

This domain is relevant for easing symptoms related to physical discomfort that is typically categorized as mild to moderate. It is used in areas where short-term symptom management is appropriate for symptomatic pain, including common ailments like headaches, dental discomfort, myalgia, and generalized body aches. Furthermore, it plays a role in managing symptoms related to systemic imbalance, specifically in reducing an elevated core body temperature (fever).

The medication is relevant in clinical scenarios where symptoms may intensify temporarily and cluster into patterns requiring supportive management. This includes providing symptomatic assistance for the aches, pains, and fevers associated with seasonal illnesses and is commonly used to help with recurrent discomforts, such as primary menstrual pain. In these situations, Paracetamol Pensa provides support that helps ease the overall symptom burden and contributes to improved comfort during periods of heightened symptoms.

“It is commonly used across conditions presenting with acute episodes and is considered relevant when supportive symptom management is appropriate.”


Quick Fact: Relief for Pain and Fever This medication helps manage a common cluster of symptoms associated with acute or episodic changes and conditions marked by increased physiological stress, offering supportive relief when symptoms interfere with routine activities.

Advertisements

Eligibility and Restrictions for Use

Paracetamol Pensa eligibility is strictly defined by regulatory bodies based on pre-existing conditions and population characteristics.

Contraindications and Restrictions

Eligibility Status Official Regulatory Rule
Contraindicated The medicine must not be used in patients with known hypersensitivity to paracetamol or its excipients, or those with severe active liver disease or severe hepatocellular insufficiency.
Restricted Use Caution is mandatory in cases of severe renal impairment and conditions associated with glutathione depletion, such as chronic alcoholism or malnutrition. Use is restricted in individuals with low body weight (< 50 kg) for standard adult formulations.

Age and Reproductive Eligibility

Use is established for adults and adolescents (typically ge 12 years). Pediatric use is allowed, though the minimum eligible age depends on the product's specific formulation and strength. For pregnancy, use is permitted if clinically necessary, but official guidelines mandate the use of the lowest effective dose for the shortest possible duration. The medicine is generally considered permitted for use while breastfeeding at normal therapeutic doses. Premature newborn infants are classified as a use-not-established group due to a lack of specific safety and efficacy data.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of Paracetamol Pensa around pharmacokinetic changes and specific pharmacodynamic risks. A key restriction is the prohibition against co-administering with other medicines containing acetaminophen to prevent the consumption of excessive total daily doses, which poses a risk for severe hepatic injury.


Documented Pharmacokinetic Interactions

Mechanism Interacting Substances (Examples)
Increased Absorption Rate Metoclopramide, Domperidone
Reduced Absorption Extent Cholestyramine
Hepatic Enzyme Induction Carbamazepine, Phenytoin, Rifampicin, St. John’s Wort

Long-term co-treatment with hepatic enzyme inducers, such as certain antiepileptics or the herbal product St. John’s Wort, is officially recognized as a risk factor for liver damage due to altered drug metabolism. Medicines that reduce absorption, like Cholestyramine, may require a time separation between administrations.


Pharmacodynamic and Substance Interactions

Regular, prolonged use of paracetamol may enhance the anticoagulant effect of warfarin and other coumarins, leading to a documented increase in bleeding risk. Concurrent use with Flucloxacillin is formally associated with the risk of high anion gap metabolic acidosis. Furthermore, regular or excessive ingestion of alcohol (ethanol) is an officially documented risk factor for severe hepatic damage when combined with paracetamol.

Advertisements

Mechanism of Action

The mechanism of action for Paracetamol (Acetaminophen) is centered in the Central Nervous System (CNS), achieved through two primary domains: highly selective enzyme inhibition and receptor pathway modulation.


Central Inhibition of Prostaglandin Synthesis

This mechanism involves the drug acting as an inhibitor of Cyclooxygenase (COX) enzymes within the hypothalamus, the brain's thermoregulatory center. By reducing the formation of Prostaglandin PGE2 in this region, the elevated temperature set-point is chemically reset, initiating the physiological processes required for heat-dissipation.


Modulation of Central Nociceptive Signaling

The drug also modulates the central processing of nociceptive signals through multi-pathway interactions. Its metabolite, AM404, engages the body's natural pain suppression mechanisms, including the Cannabinoid ( CB1) receptors and Serotonergic pathways. This action directly enhances the descending inhibitory signals that dampen the transmission of nociceptive input, thereby modulating central sensitivity.


Mechanistic Specificity and Constraints

The drug's activity is highly confined to the CNS because its inhibitory effect on COX is effective only in the brain's low-peroxide environment. This mechanistic specificity means the drug is structurally unable to exert a strong effect on COX in the peripheral tissues, resulting in a lack of robust COX inhibition in peripheral tissues.

Advertisements

Dosage and Administration Information

How to Use Paracetamol Pensa: Official Administration Guidelines

The administration of Paracetamol Pensa is governed by official instructions detailing the precise route, dosage, frequency, and duration of use.

Administration Scope

Feature Description (Strictly Label-Based)
Route of administration Oral administration by swallowing the tablet whole.
Dosing schedule (Adults ge 50 kg) Single Dose: 500 mg to 1,000 mg. Maximum Total Daily Dose: 4,000 mg (4 g) in 24 hours.
Timing in relation to meals May be taken with or without food. Taking without food may accelerate the onset of effect.
Preparation requirements The tablet must be ingested whole with a drink of liquid (e.g., water).
Age-group administration rules The standard regimen is for adults and adolescents weighing 50 kg or more.
Missed-dose rules If a dose is missed, simply take the next scheduled dose, ensuring the minimum time interval is met.
Special procedural conditions The maximum daily dose is required to be reduced for patients with chronic alcoholism or hepatic impairment. The minimum 4-hour interval must be prolonged for individuals with severe renal impairment.

Instruction Classifications (High-Level)

Classification Detail
Administration method type Oral (swallowing a solid tablet).
Frequency pattern As-needed (Intermittent use), repeated every 4 to 6 hours, with a mandatory minimum 4-hour interval.
Regulatory basis Governed by guidelines aligned with official prescribing information.
Use-context constraints Officially designated for short-term use only, such as 3 days for fever or up to 10 days for pain relief, unless directed otherwise.

Connection to the Overall Use Protocol

The protocol for Paracetamol Pensa establishes a structured, non-maintenance pattern of administration defined by a precise single-dose range and a mandatory 4-hour minimum interval. This structure dictates that the drug is used only for short, defined periods and strictly governs the minimum interval between doses. It also mandates specific dose modification logic for individuals with low body weight or impaired organ function, formalizing the application of the drug's therapeutic range.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Phase 3 Clinical Trials and Research Focus

Research on the compound includes multiple Phase 3 randomized, placebo-controlled trials that focused primarily on the research focus on pain management in conditions affecting the muscles and skeleton.

Studies examined whether the compound affected pain scores using established scales (e.g., VAS, BPI) over a period of 12 weeks. Research also examined changes in pain levels over time in comparison to the control groups, and some studies evaluated whether the quality of life was affected during the trial period.


Safety and Long-Term Tolerability

Research has explored the use of the compound for chronic conditions, which requires extended treatment periods. Studies reviewed the safety profile and tolerability during long-term use, including in elderly study participants. Studies recorded mild gastrointestinal upset and headache as frequent occurrences. The research did not report any major or unexpected safety signals among the primary study participants. However, some observational studies in older adults using the compound repeatedly over the long term have suggested an association with an increased risk of certain cardiovascular, gastrointestinal, and renal complications.


Specific Condition Research

Acute Pain Management

Studies investigated the time to onset of action and effects on acute pain following procedures such as dental surgery. A pooled analysis of four trials explored comparative outcomes against a non-pharmacological intervention, and the findings contributed to understanding the compound's profile in time-limited pain management.

Chronic Pain and Combination Therapies

Research has investigated the compound's use in chronic conditions, such as osteoarthritis and low back pain. While evidence for the compound as a single ingredient in these specific conditions is often considered limited, studies have evaluated the use of the compound in combination with other analgesics, such as Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

Studies evaluated whether the combination affected joint mobility and stiffness scores in individuals with osteoarthritis. Low-to-moderate quality evidence supports the oral use of some combinations for short-term pain relief without an increased risk of adverse events compared to the non-paracetamol monotherapy component.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Paracetamol Pensa (FAQ)


Q: What are the common ingredients in Paracetamol Pensa besides the active substance?

According to the official product information, the Paracetamol Pensa tablet contains the active substance paracetamol along with several non-active ingredients, known as excipients. These can include sodium starch glycolate, pregelatinized starch, povidone K30, stearic acid, and crospovidone. These ingredients are used to ensure the stability and proper formation of the tablet.


Q: Is Paracetamol Pensa sold over the counter or does it require a prescription?

Paracetamol, the active substance in Paracetamol Pensa, is generally classified by regulatory bodies as an over-the-counter (OTC) medicine. This classification generally means it is available without a doctor's prescription, though specific regulatory requirements apply to its sale, which can vary by country.


Q: Are there any age restrictions mentioned in the official documents for Paracetamol Pensa?

Official documents for the standard Paracetamol Pensa 500 mg tablet formulation typically state that the medicine is not recommended for children under 10 years of age. The standard regimen described in regulatory documents is designed for adults and adolescents weighing 50 kg or more.


Q: What does official guidance say about using Paracetamol Pensa while breastfeeding?

Regulatory guidance indicates that Paracetamol Pensa is generally permitted for use while breastfeeding when taken at normal therapeutic doses. Official mandates generally recommend using the lowest effective dose for the shortest possible duration.


Q: What is the typical time frame for Paracetamol Pensa to be cleared from the body?

Pharmacokinetic information shows that the active substance in Paracetamol Pensa has a plasma half-life of approximately 1.5 to 2.5 hours. The plasma half-life is a measure of the time needed for the amount of the substance in the bloodstream to be reduced by half.


Q: Are there different strengths of Paracetamol Pensa available?

Paracetamol Pensa can be available in different strengths. Commonly available strengths for oral tablets include 500 mg or 1,000 mg formulations, depending on the product’s local authorization and the specific regulatory region.


Q: Does Paracetamol Pensa cause drowsiness?

Drowsiness is not listed among the common or frequent side effects of Paracetamol Pensa when the medication is taken at recommended doses. Extreme drowsiness or dizziness is noted in regulatory information as a potential sign of a very rare, severe allergic reaction.


Q: Is Paracetamol Pensa generally considered a strong pain reliever?

In therapeutic guidelines, Paracetamol is consistently defined as an agent used for the relief of mild to moderate pain and fever. Its classification as a pain reliever relates to this specific range of pain intensity.


Q: Is it possible to become dependent on Paracetamol Pensa?

Regulatory documents do not list dependence as a known risk associated with this type of non-opioid analgesic medicine. However, official warnings caution that prolonged or frequent use of any pain reliever can potentially lead to a condition known as medication-overuse headache.


Q: What does 'Pensa' refer to in the name of the medicine?

'Pensa' refers to Pensa Pharma, which is the pharmaceutical company that holds the marketing authorization for or distributes this specific formulation of paracetamol. This company is responsible for the distribution and management of the product.


Q: Can Paracetamol Pensa interact with herbal supplements?

Regulatory documentation explicitly warns about potential interactions with the herbal product St. John’s Wort. This is because St. John’s Wort may alter the metabolism of paracetamol, which is a documented risk factor for liver damage.


Q: Is Paracetamol Pensa safe to use if I have stomach issues?

Paracetamol Pensa is not associated with the same risks of gastrointestinal bleeding or ulceration that are sometimes linked to other classes of pain relievers. However, clinical research has noted mild gastrointestinal upset as a frequent occurrence when using the compound.


Q: Can older adults typically use Paracetamol Pensa?

Official product information notes that older adults can use Paracetamol Pensa. It is advised to be mindful of the dose, as an increased elimination half-life has been observed in this population. The regulatory information describes that specific dose adjustments may be necessary due to altered metabolism in this population.


Q: What is the expected duration of the pain relief from Paracetamol Pensa?

The official dosing instructions in regulatory documents state that a dose may be repeated every 4 to 6 hours. This interval generally reflects the anticipated duration of the therapeutic effect for pain or fever relief.


Q: Why do some people say Paracetamol Pensa works faster than other types?

Official administration guidelines indicate that the conditions of use can affect the speed of the medicine’s onset. Specifically, taking the medicine without food may accelerate the onset of the effect compared to taking it with food.


Q: Can Paracetamol Pensa affect my blood pressure?

Blood pressure changes are not commonly listed as a known adverse effect in the regulatory safety profile of Paracetamol Pensa when taken as directed. The determination of suitability is based on an individual’s overall medical profile.


Q: What should I know about taking Paracetamol Pensa if I have kidney issues?

For individuals with severe renal (kidney) impairment, official documents advise that the minimum time interval between doses must be prolonged. This prolongation is mandatory for individuals with severe renal impairment, according to official administration guidelines.


Q: Can people with diabetes use Paracetamol Pensa?

There is no general contraindication for use by individuals with diabetes. However, patients should be aware that some formulations of paracetamol, particularly non-tablet forms, may contain small amounts of glucose. Reviewing the full list of excipients is advised to verify the content.


Q: Is there any evidence about Paracetamol Pensa use during pregnancy?

Official guidance states that Paracetamol Pensa is permitted for use during pregnancy if clinically necessary. The regulatory mandate specifies that the medicine should be used at the lowest effective dose for the shortest possible duration.


Q: Can Paracetamol Pensa be used for toothache?

Yes, official indications for Paracetamol Pensa include the short-term symptomatic management of various types of pain. This commonly includes conditions such as toothache, as well as general muscle and body aches.


Q: Do studies show that Paracetamol Pensa is well-tolerated?

Research indicates that the compound is generally well-tolerated when used within the therapeutic dose range. Studies reviewed the safety profile and tolerability during long-term use and noted mild gastrointestinal upset and headache as frequent occurrences.


Q: Does taking Paracetamol Pensa with food change how it works?

Official guidelines state the medicine can be taken with or without food. Taking it without food may lead to a faster onset of the effect, but it does not significantly change the overall amount of the substance absorbed by the body.


Q: Does Paracetamol Pensa contain lactose or gluten?

The excipients listed in the product information for the standard Paracetamol Pensa 500 mg tablet do not generally include lactose. Individuals with gluten sensitivities may wish to review the full excipient list to verify the source of starches used in the tablet, if applicable.


Q: Are there any specific activities or foods to avoid while taking Paracetamol Pensa?

The primary substance officially warned against is alcohol (ethanol), as regular or excessive ingestion is an officially documented risk factor for severe hepatic (liver) damage when combined with paracetamol. No specific restrictions on food or other general activities are typically noted in the regulatory documents.


Q: Why is Paracetamol Pensa sometimes recommended for common colds and flu symptoms?

Regulatory indications state that Paracetamol Pensa is recommended for the symptomatic relief of general aches, pains, and fever. Since high temperature and body aches are common symptoms associated with colds and influenza, the medicine addresses these specific discomforts.


Q: What are the official warnings about potential allergic reactions to Paracetamol Pensa?

Official warnings list hypersensitivity reactions as rare adverse effects. Severe hypersensitivity reactions, including anaphylactic shock and severe cutaneous adverse reactions (SCARs), are documented but are considered very rare risks.


Q: Are there any studies comparing Paracetamol Pensa's effectiveness across different pain types?

Research has examined the compound’s effect across various pain types. Studies have focused on pain associated with the muscles and skeleton, acute pain following procedures, and chronic conditions such as osteoarthritis and low back pain.


Q: How is the quality of Paracetamol Pensa ensured by the regulatory bodies?

The quality and consistency of the medicine are ensured by its approval through major regulatory agencies, such as the EMA, FDA, or TGA. These bodies enforce strict standards for manufacturing practices and post-market safety monitoring.


Q: What type of pain relief is Paracetamol Pensa commonly associated with?

Paracetamol Pensa is officially associated with the relief of mild to moderate pain and fever. Its therapeutic purpose is focused on enhancing comfort and managing febrile episodes.


Q: Can Paracetamol Pensa affect my sleep?

Effects on sleep are not listed as a common or frequent adverse reaction in the regulatory safety profile for Paracetamol Pensa when used as directed. The medicine’s primary effects are focused on pain and fever relief.


Q: Is there a list of ingredients that should be avoided when taking Paracetamol Pensa?

Official documentation includes a list of substances to be aware of, as they may interact with paracetamol. These include the anticoagulant warfarin, the herbal product St. John’s Wort, alcohol (ethanol), and certain enzyme-inducing medicines.


Q: Can people with asthma generally use Paracetamol Pensa?

Regulatory safety information notes that paracetamol is generally considered an appropriate option for pain relief in asthmatic patients. However, there are very rare reports of aggravation of bronchospasm in individuals sensitive to aspirin or other NSAIDs.


Q: Is there any difference in how Paracetamol Pensa is absorbed compared to other brands?

Regulatory standards for generic and innovator products generally ensure that the active substance in different brands is absorbed and performs comparably. While non-active ingredients can sometimes influence the speed of absorption, the overall therapeutic effect is required to be equivalent.


Q: Are there different forms of the medicine, like liquid or effervescent tablets?

Paracetamol, the active ingredient in Paracetamol Pensa, is commonly available in various oral forms beyond film-coated tablets. Depending on the specific product line and region, this may include soluble (effervescent) tablets or liquid formulations.


Q: Is there a maximum number of days Paracetamol Pensa should be used without a break?

Official regulatory protocols designate the medicine for short-term use only. This is typically defined as up to 3 days for the symptomatic relief of fever, or up to 10 days for pain relief.


Q: Is it normal to feel a mild stomach upset after taking Paracetamol Pensa?

Yes, clinical research has recorded mild gastrointestinal upset as a frequent occurrence when using the compound. This is generally a minor reaction that occurs within the therapeutic dose range.


Q: Can I use Paracetamol Pensa if I am taking medicines for cholesterol?

Regulatory documentation does not list a common interaction between paracetamol and most cholesterol-lowering medicines, such as statins. A comprehensive review of all current medicines is generally advised when starting a new treatment.

Advertisements

How should Paracetamol Pensa be stored and disposed of?

How to Store and Dispose of Paracetamol Pensa?

This section outlines the official, regulated requirements for storing and disposing of this medicine, based on government regulatory labeling.

Mandatory Storage Requirements

Official documents mandate that the medicine must be stored in its original packaging to ensure protection from moisture and light. Storage should generally be in a dry, cool, and well-ventilated location, with some licenses specifying conditions mathbfbelow 30^circC. It is mandatory to keep this medicine out of the sight and reach of children.

Disposal and Stability Rules

Paracetamol Pensa must not be used after the expiry date shown on the package. The disposal process is subject to regulation: unused or expired tablets must not be discarded in household waste or wastewater. Instead, the product must be returned to a pharmacist or collected via an approved disposal plant in accordance with local environmental requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Paracetamol Pensa found in:

A-Z Index: